Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0GNWGF
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
CN114917361A ADC-3
|
|||||
| Synonyms |
CN114917361A_ADC-3
Click to Show/Hide
|
|||||
| Organization |
Bayer Pharma AG
|
|||||
| Drug Status |
Investigative
|
|||||
| Indication |
In total 2 Indication(s)
Lung cancer [ICD11:2C25]
Investigative
Skin squamous cell carcinoma [ICD11:2C31]
Investigative
|
|||||
| Drug-to-Antibody Ratio |
3.1
|
|||||
| Antibody Name |
Nimotuzumab
|
Antibody Info | ||||
| Antigen Name |
Epidermal growth factor receptor (EGFR)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Linker Name |
CN114917361A ADC-3 linker
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.